12:00 AM
May 11, 2015
 |  BC Week In Review  |  Company News  |  Deals

Auspex, Teva deal

Teva completed its acquisition of neurology play Auspex for $101 per share...

Read the full 39 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >